BSECompany Update2 Nov 2026 · 2 Nov 2026, 12:46 pm
Update on acquisition of API business
Zydus Lifesciences Ltd · 532321
✦ AI Summary▲ PositiveM&A
Zydus Lifesciences Ltd has completed the acquisition of the API Business of Sterling Biotech Limited, as per the Business Transfer Agreement dated September 17, 2024.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Attachments (1)
📄pdf
Download →
efa46e72-a417-46fa-93c7-740b0cf08b4e.pdf
View document text
November 2, 2026
Listing Department Code: 532321 Listing Department Code: Zyduslife
BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA
P J Towers, LIMITED
Dalal Street, Exchange Plaza,
Fort, Mumbai-400001 Bandra Kurla Complex, Bandra (E),
Mumbai-400051
Re.: Update on acquisition of API business
Ref.: 1. Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
2. Closing of acquisition of API Business of Sterling Biotech Limited
Dear Sir / Madam,
In continuation with earlier intimation, on completion of conditions precedent and closing date
adjustments as specified in the Business Transfer Agreement entered into between the Company
and Sterling Biotech Limited dated September 17, 2024, we hereby inform that the Company
has completed the acquisition of the API Business of Sterling Biotech Limited.
Kindly take the same on record.
Thanking you,
Yours faithfully,
For, Zydus Lifesciences Limited
Dhaval N. Soni
Company Secretary and Compliance Officer
Membership No. FCS7063